The DOI matches its Crossref record.
Posaconazole treatment of refractory eumycetoma and chromoblastomycosis
Open accessAbstract
Eumycetoma and chromoblastomycosis are chronic, disfiguring fungal infections of the subcutaneous tissue that rarely resolve spontaneously. Most patients do not achieve sustained long-term benefits from available treatments; therefore, new therapeutic options are needed. We evaluated the efficacy of posaconazole, a new extended-spectrum triazole antifungal agent, in 12 patients with eumycetoma or chromoblastomycosis refractory to existing antifungal therapies. Posaconazole 800 mg/d was given in divided doses for a maximum of 34 months. Complete or partial clinical response was considered a success; stable disease or failure was considered a nonsuccess. All 12 patients had proven infections refractory to standard therapy. Clinical success was reported for five of six patients with eumycetoma and five of six patients with chromoblastomycosis. Two patients were reported to have stable disease. As part of a treatment-use extension protocol, two patients with eumycetoma who initially had successful outcome were successfully retreated with posaconazole after a treatment hiatus of > 10 months. Posaconazole was well tolerated during long-term administration (up to 1015 d). Posaconazole therapy resulted in successful outcome in most patients with eumycetoma or chromoblastomycosis refractory to standard therapies, suggesting that posaconazole may be an important treatment option for these diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Melanized Fungi in Human Disease
Revankar, S. G., & Sutton, D. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-10 · Cited by 569
Chowdhary, A., Meis, J. F., Guarro, J., de Hoog, G. S., Kathuria, S., Arendrup, M. C., Arikan-Akdagli, S., Akova, M., Boekhout, T., Caira, M., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12515 · Cited by 374
Queiroz-Telles, F., de Hoog, S., Santos, D. W. C. L., Salgado, C. G., Vicente, V. A., Bonifaz, A., Roilides, E., Xi, L., Azevedo, C. D. M. P. E. S., da Silva, M. B., et al. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00032-16 · Cited by 360
Mycetoma: a unique neglected tropical disease
Zijlstra, E. E., van de Sande, W. W. J., Welsh, O., Mahgoub, E. S., Goodfellow, M., & Fahal, A. H. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00359-x · Cited by 346
Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment
Queiroz-Telles, F., Esterre, P., Perez-Blanco, M., Vitale, R. G., Salgado, C. G., & Bonifaz, A. (2009) · Medical Mycology · doi:10.1080/13693780802538001 · Cited by 333
Metadata
- Authors
- Negroni, R., Tobón, A., Bustamante, B., Shikanai-Yasuda, M. A., Patino, H., & Restrepo, A.
- Venue
- Revista do Instituto de Medicina Tropical de São Paulo
- Publisher
- FapUNIFESP (SciELO)
- Published
- 2005-12
- Volume
- 47
- Issue
- 6
- Pages
- 339-346
- ISSN
- 0036-4665 (ISSN-L)
- OpenAlex
- W2112811350
- Cited by
- 158
- References
- 0
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. https://app.cochat.ai/papers/10.1590/s0036-46652005000600006
- The paper
- Negroni, R., Tobón, A., Bustamante, B., Shikanai-Yasuda, M. A., Patino, H., & Restrepo, A. (2005). Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Revista do Instituto de Medicina Tropical de São Paulo. https://doi.org/10.1590/s0036-46652005000600006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.